Royalty Pharma Reports Q4 and Full Year 2024 Results

Go back to Royalty Pharma Reports Q4 and Full Year 2024 Results
REPROS THERAPEUTICS (NASDAQ: RPRX) Delayed: 54.51 +0.94 (1.75%)
Previous Close $53.57    52 Week High $3.48 
Open $53.58    52 Week Low $0.80 
Day High $54.56    P/E N/A 
Day Low $53.31    EPS $-1.54 
Volume 392,938